BrightSpec, Inc.

Charlottesville, VA · Founded 2012 · Medtech · Still private

Laser Induced Acoustic Desorption (LIAD) sample introduction system for Molecular Rotational Resonance (MRR) spectrometers

Claim this profile

Follows are private to you and power your alerts

Updated · brightspec.com

Sector
Medtech
Headquarters
Charlottesville, VA
Founded
2012
Latest Form D
$3.9M, May 2025
Total capital
$22.3M
Federal grants
$6.5M
7 awards · 2014–2025
Rank in peer group#82 of 538
Private capital raised
$15.9M
5 Form D · last May 2025
18 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
5
10 pending · first 2018
Rank in peer group#111 of 538

Capital timeline

201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $22.3M$999K$996K$1M$1M$647K$1.2M1st Form D$1.6M2nd Form D$2.1M4th Form D$7.5M
201420162018202020222024FEDERAL ↑EQUITY ↓Cumulative $22.3M$999K$1M$1M$1.2M2nd Form D$2.1M

Latest events

  • Federal grantHealth and Human S · Phase II · MR^3: Development of a Molecular Rotational Resonance Ratiometer$1.2M
  • Private capital raisedForm D · SEC · 5th filing$3.9M
  • Federal grantHealth and Human S · Phase II · Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy$647K
  • Federal grantHealth and Human S · Phase II · Novel Sample Introduction Methodologies for Molecular Rotational Resonance (MRR) Spectroscopy$1M
  • Private capital raisedForm D · SEC · 4th filing$7.5M
  • Private capital raisedForm D · SEC · 3rd filing$825K
  • Federal grantHealth and Human S · Phase II · Gas Chromatography-Molecular Rotational Resonance Spectrometer$604K
  • Private capital raisedForm D · SEC · 2nd filing$2.1M
  • Private capital raisedForm D · SEC · 1st filing$1.6M
Show 3 earlier federal awards
  • Federal grantHealth and Human S · Phase II · Gas Chromatography-Molecular Rotational Resonance Spectrometer$1M
  • Federal grantNSF · Phase II · SBIR Phase II: A Programmable Residual Solvent Analyzer based on Fourier Transform Molecular Rotational Resonance (FT-MRR) Spectroscopy$996K
  • Federal grantDefense · Phase II · Automated trace gas molecular analyzer using rotational spectroscopy$999K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

7months

from BrightSpec, Inc.’s first federal award to its first private round.

First federal award · Nov 2014
Defense · $999K
First Form D · May 2015
$1.6M · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grants#82 · top 15%
  • Granted patents#111 · top 21%
  • Linked publications#38 · top 7%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Dan KidleDirectorNamed in SEC Form D filings
  • David CashDirectorNamed in SEC Form D filings
  • DAVID MCDANIELExecutive Officer, DirectorNamed in SEC Form D filings
  • George KastendikeDirectorNamed in SEC Form D filings
  • JAFFRAY WOODRIFFDirectorNamed in SEC Form D filings
  • Jenny RookeDirectorNamed in SEC Form D filings
Show all 12 people
  • Robert CreedenDirectorNamed in SEC Form D filings
  • ROBERT LLOYDExecutive Officer, DirectorNamed in SEC Form D filings
  • Terry DunlayDirectorNamed in SEC Form D filings
  • THOMAS JONESDirectorNamed in SEC Form D filings
  • Timothy GermannDirectorNamed in SEC Form D filings
  • WALTER COLSMANDirectorNamed in SEC Form D filings

What it has protected

USPTO · 5 granted of 15
Show all 15 patent records

Recent research by its founders

  • Application of Laser-Induced Acoustic Desorption for Molecular Rotational Resonance Spectroscopy20245 cites
  • Relativistic effects in the gas-phase molecular hydration of heavy atomic transition metal cations (Groups 10–12): Group variations in energetics and kinetics20241 cites
  • Relativistic Effects on Rate and Product Formation in the Gas‐Phase Methane Chemistry of Late Atomic Transition Metal Cations20234 cites
  • ATHEM L.L.C.Similar federal contract value in Medtech · null in contracts
  • Rapa Technologies LLCSimilar federal contract value in Medtech · null in contracts
  • Mitra EV, Inc.Similar federal contract value in Medtech · null in contracts
  • REFINED IMAGING, LLCSimilar federal contract value in Medtech · null in contracts
  • CROSSMHV, L.L.CSimilar federal contract value in Medtech · null in contracts
  • MITOLUMINATE, LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .